Cerus Endovascular Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$525M
- Investors
-
1
Cerus Endovascular General Information
Description
Developer of proprietary interventional neuroradiology devices designed to support the treatment of neurovascular diseases. The company's neuroradiology devices are used for the treatment of hemorrhagic strokes and a range of aneurysm morphologies, including unruptured wide-necked bifurcation and bifurcation aneurysms, thereby enabling interventional neuroradiologists to treat minimally invasive neurovascular diseases, particularly intracranial aneurysms.
Contact Information
Website
www.cerusendo.com(Operating Subsidiary)
Corporate Office
- John Eccles House
- Oxford Science Park
- Oxford OX4 4GP
- England, United Kingdom
Corporate Office
- John Eccles House
- Oxford Science Park
- Oxford OX4 4GP
- England, United Kingdom
Cerus Endovascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 01-May-2023 | $525M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series B) | 21-Feb-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 21-Jul-2016 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 30-Jun-2015 | Completed | Generating Revenue | |||
| 3. Early Stage VC | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A) | 03-May-2013 | $3M | $3M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2011 | Completed | Startup |
Cerus Endovascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 33,789 | $0.000065 | $77.35 | $77.35 | 1x | $77.35 | 5.45% | |
| Series A | 140,388 | $0.000065 | $19.53 | $19.53 | 1x | $19.53 | 22.66% |
Cerus Endovascular Comparisons
Industry
Financing
Details
Cerus Endovascular Competitors (1)
One of Cerus Endovascular’s competitors is AngioCare, a Corporate Backed or Acquired company based in Amersfoort, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AngioCare | Corporate Backed or Acquired | Amersfoort, Netherlands |
Cerus Endovascular Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cerus Endovascular Patents
Cerus Endovascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3168316-A1 | Clot removal distal protection methods | Pending | 20-Feb-2020 | ||
| CA-3073232-A1 | Occlusion device | Active | 21-Aug-2017 | ||
| CA-3073232-C | Occlusion device | Active | 21-Aug-2017 | ||
| ES-2971315-T3 | Occlusion device | Active | 21-Aug-2017 | ||
| CA-3016679-A1 | Occlusion device | Pending | 11-Mar-2016 | A61B17/12122 |
Cerus Endovascular Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cerus Endovascular Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Andover Ventures | Venture Capital | Minority | ||
| Epiphany Capital | Venture Capital | Minority | ||
| Innovate UK | Government | Minority | ||
| Angel (individual) | Minority | |||
| Johnston Associates | Venture Capital | Minority |
Cerus Endovascular FAQs
-
When was Cerus Endovascular founded?
Cerus Endovascular was founded in 2011.
-
Where is Cerus Endovascular headquartered?
Cerus Endovascular is headquartered in Oxford, United Kingdom.
-
What is the size of Cerus Endovascular?
Cerus Endovascular has 12 total employees.
-
What industry is Cerus Endovascular in?
Cerus Endovascular’s primary industry is Therapeutic Devices.
-
Is Cerus Endovascular a private or public company?
Cerus Endovascular is a Private company.
-
What is the current valuation of Cerus Endovascular?
The current valuation of Cerus Endovascular is .
-
What is Cerus Endovascular’s current revenue?
The current revenue for Cerus Endovascular is .
-
How much funding has Cerus Endovascular raised over time?
Cerus Endovascular has raised $37.3M.
-
Who are Cerus Endovascular’s investors?
Andover Ventures, Epiphany Capital, Innovate UK, , and Johnston Associates are 5 of 8 investors who have invested in Cerus Endovascular.
-
Who are Cerus Endovascular’s competitors?
AngioCare is a competitor of Cerus Endovascular.
-
When was Cerus Endovascular acquired?
Cerus Endovascular was acquired on 01-May-2023.
-
Who acquired Cerus Endovascular?
Cerus Endovascular was acquired by Stryker.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
